MannKind Corp (NASDAQ:MNKD)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.

Recs

0
Player Avatar jeffrycooks (69.40) Submitted: 2/6/2012 10:17:43 PM : Outperform Start Price: $2.40 MNKD Score: -27.21

shorts

Featured Broker Partners


Advertisement